Open Orphan plc changed its name to hVIVO plc on 26 October 2022, learn more
here
.
About Us
About hVIVO
Leadership Team
Our Companies
Key Stats
History
Services
New
Challenge Trials
RSV
Influenza
COVID-19
HRV
Malaria
Asthma & COPD
hMPV
Phase II-III Trials
Vaccine Phase II-III Trials
Laboratory Services
Assay Development
Field Trial Bio-logistics
Cell Based Assays
Molecular Services
Compound Efficacy & VRM
Biomarker Analysis
Articles & Research
News & Media
Regulatory News
Media Coverage
Media Press Kit
Video Library
Events
Investors
New
Investors
Regulatory News & Email Alerts
Results Centre
Share Price Information
Events & Presentations
Environmental, Social & Governance
AIM Rule 26
Advisors
Documents
Corporate Governance
Volunteers
Careers
Contact Us
Contact Us
Articles & Research
from hVIVO
Article Types Filter
Article Types Filter
Blog
Article
Presentation
Scientific Paper
Factsheet
Case Study
Article Count
1 - 10 of 42 posts
02 Apr 2019
hVIVO and Imutex Limited to present at IVW 2019 conference, Edinburgh, Scotland, April
Influenza Vaccines For The World 2019, April 02 - 04, Edinburgh, Scotland. hVIVO and its joint venture, Imutex Limited, will present at the Influenza Vaccines for the World (IVW 2019)...
Read more
18 Mar 2019
hVIVO's Alex Mann making an oral presentation at ISRIV 1st Influenza Vaccine Group Meeting, Siena, Italy, March
ISRIV 1st Influenza Vaccine Group Meeting, March 31st - April 2nd, Siena, Italy Alex Man, hVIVO’s Director Clinical Science R&D Operations, will be making an oral presentation at ISRIV 1st Influenza...
Read more
Article Pagination
1
2
3
4
5
Articles Per Page
Articles Per Page
8
10
16
24
32
angle-down
meetup
chevron-down